KVK-Tech Recalls Phentermine Hydrochloride Capsules Due to Impurity Failures
KVK-Tech is recalling specific lots of Phentermine Hydrochloride Capsules because they failed impurity specifications during stability testing.
What this means for you
Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.
Our severity reasoning: The recall is classified as FDA Class III, which the rubric defines as typically resulting in a score of 1 or 2 because it is unlikely to cause adverse health consequences.
Plain-English summary
KVK-Tech, Inc. is recalling specific lots of Phentermine Hydrochloride Capsules, USP, 15 mg. The affected products are packaged in 100-count and 1,000-count bottles and are distributed nationwide. The recall involves approximately 9,696 bottles of the 100-count size and 972 bottles of the 1,000-count size.
The recall was initiated because the products failed impurities and degradation specifications. Specifically, out-of-specification results were found for individual unknown and total impurity at the 12th month room temperature stability test station. The affected lot numbers are 11957A (100-count) and 11956A (1,000-count), both with an expiration date of 04/2017.
Consumers and healthcare providers should check their inventory for these specific NDCs and lot numbers. If the products are found, they should be returned to the distributor or disposed of according to local regulations. This is an FDA Class III recall, indicating that the violation is not likely to cause adverse health consequences.
The recalled product
- Product
- Phentermine Hydrochloride Capsules, USP, 15 mg, packaged in a) 100-count bottle (NDC 10702-0026-01; UPC 3 10702 02601 8) and b) 1000-count bottle (NDC 10702-0026-10; UPC 3 10702 02601 0); Rx only, Mfd. by KVK-TECH, Inc., Newtown, PA
- Manufacturer
- KVK-Tech, Inc.
- Category
- Drug — Prescription Medication
- Hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- Lot #: a) 11957A
- Exp 04/2017
- b) 11956A
Distribution
Distributed nationwide across the United States.
Related recalls
Same manufacturer · KVK-Tech, Inc.
See all →- ModeratePhentermine Hydrochloride Capsules 30mg Recalled for cGMP Deviations
FDA (Drugs) · 2025-05-28
- ModerateIndomethacin Extended-Release Capsules Recalled for cGMP Deviations
FDA (Drugs) · 2025-05-28
- SevereBetaxolol Hydrochloride tablets recalled due to oxycodone contamination
FDA (Drugs) · 2023-10-25
- SevereAtovaquone Oral Suspension Recalled for Temperature Abuse
FDA (Drugs) · 2021-09-01
- ModerateKVK-Tech Recalls Hydrocodone and Homatropine Tablets for Impurity Failures
FDA (Drugs) · 2021-05-26
Same hazard · impurity
See all →- ModerateHikma Recalls Ramipril Capsules Due to Process Impurity
FDA (Drugs) · 2026-09-02
- ModerateMedline Remedy Specialized Silicone Cream Recalled for Elevated Formaldehyde Levels
FDA (Drugs) · 2026-07-15
- SevereCinacalcet Hydrochloride Tablets Recalled for Elevated Impurity Levels
FDA (Drugs) · 2026-07-08
- HighDuloxetine 30mg delayed-release capsules exceed nitrosamine impurity interim limit
FDA (Drugs) · 2026-06-17
- HighDuloxetine 60mg delayed-release capsules exceed nitrosamine impurity interim limit
FDA (Drugs) · 2026-06-17